Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism

Cancer Prevention Research

Volumn 3, Issue 6, 2010, Pages 727-737

  Aiyer, Harini S ^a   Gupta, Ramesh C ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; ELLAGIC ACID; ESTRADIOL; ESTROGEN; STEROID RECEPTOR; TESTOSTERONE 17BETA DEHYDROGENASE; 3 (OR 17)-BETA-HYDROXYSTEROID DEHYDROGENASE; CYP1B1 PROTEIN, RAT; ESTROGEN RECEPTOR; GLUTATHIONE S-TRANSFERASE ALPHA; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; HYDROXYSTEROID DEHYDROGENASE; ISOENZYME; PROGESTERONE RECEPTOR; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BERRY; BREAST; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER INCIDENCE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; ENZYME REGULATION; ESTROGEN METABOLISM; FEMALE; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; BLUEBERRY; CELL TRANSFORMATION; DRUG SCREENING; ENZYMOLOGY; FRUIT; GENETICS; INBRED RAT STRAIN; MAMMARY NEOPLASMS, EXPERIMENTAL; METABOLISM; NEOPLASMS, HORMONE-DEPENDENT; PHYTOTHERAPY; RANDOMIZATION; ROSACEAE;

17-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BLUEBERRY PLANT; CATECHOL O-METHYLTRANSFERASE; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 CYP1A1; DRUG SCREENING ASSAYS, ANTITUMOR; ELLAGIC ACID; ESTROGENS; FEMALE; FRUIT; GLUTATHIONE TRANSFERASE; ISOENZYMES; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASMS, HORMONE-DEPENDENT; PHYTOTHERAPY; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; ROSACEAE; CYTOCHROME P-450 CYP1B1;

EID: 77953528472     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0260     Document Type: Article

References (47)

1. Yabroff KR, Bradley CJ, Mariotto AB, Brown ML, Feuer EJ. Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst 2008;100:1755-62.
2. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.
3. Lippman ME, Krueger KA, Eckert S, et al. Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. J Clin Oncol 2001;19:3111-6.
4. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
5. Sasano H, Suzuki T, Nakata T, Moriya T. New development in intracrinology of breast carcinoma. Breast Cancer 2006;13:129-36.
6. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225-30.
7. Luu-The V. Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 2001;76:143-51.
8. Miettinen MM, Poutanen MH, Vihko RK. Characterization of estrogen-dependent growth of cultured MCF-7 human breast-cancer cells expressing 17β-hydroxysteroid dehydrogenase type 1. Int J Cancer 1996;68:600-4.
9. Duan WR, Parmer TG, Albarracin CT, Zhong L, Gibori G. PRAP, a prolactin receptor associated protein: its gene expression and regulation in the corpus luteum. Endocrinology 1997;138:3216-21.
10. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 2000;21:40-54.
11. McFadyen MC, Breeman S, Payne S, et al. Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. J Histochem Cytochem 1999;47:1457-64.
12. Rogan EG, Badawi AF, Devanesan PD, et al. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 2003;24:697-702.
13. Liehr JG. Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. Eur J Cancer Prev 1997;6:3-10.
14. Abel EL, Lyon RP, Bammler TK, et al. Estradiol metabolites as isoform-specific inhibitors of human glutathione S-transferases. Chem Biol Interact 2004;151:21-32.
15. Lakhani NJ, Venitz J, Figg WD, Sparreboom A. Pharmacogenetics of estrogen metabolism and transport in relation to cancer. Curr Drug Metab 2003;4:505-13.
16. Gallicchio L, Berndt SI, McSorley MA, et al. Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease. BMC Cancer 2006;6:173.
17. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998;19:1-27.
18. Mauvais-Jarvis P, Kuttenn F, Gompel A. Estradiol/progesterone interaction in normal and pathologic breast cells. Ann N Y Acad Sci 1986;464:152-67.
19. Stoner GD. Foodstuffs for preventing cancer: the preclinical and clinical development of berries. Cancer Prev Res 2009;2:187-94.
20. Daniel EM, Krupnick AS, Heur Y, Blinzler JA, Nims RW, Stoner GD. Extraction, stability and quantitation of ellagic acid in various fruits and nuts. J Food Compos Anal 1989;2:338-49.
21. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 2006;54:4069-75.
22. Seeram NP. Berry fruits: compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease. J Agric Food Chem 2008;56:627-9.
23. Seeram NP. Berry fruits for cancer prevention: current status and future prospects. J Agric Food Chem 2008;56:630-5.
24. Aiyer HS, Srinivasan C, Gupta RC. Dietary berries and ellagic acid diminish estrogen-mediated mammary tumorigenesis in ACI rats. Nutr Cancer 2008;60:227-34.
25. Aiyer HS, Kichambare S, Gupta RC. Prevention of oxidative DNA damage by bioactive berry components. Nutr Cancer 2008;60 Suppl 1:36-42.
26. Schmitt E, Stopper H. Estrogenic activity of naturally occurring anthocyanidins. Nutr Cancer 2001;41:145-9.
27. Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, Tomas-Barberan FA, Espin JC. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 2006;54:1611-20.
28. Borges G, Roowi S, Rouanet JM, Duthie GG, Lean ME, Crozier A. The bioavailability of raspberry anthocyanins and ellagitannins in rats. Mol Nutr Food Res 2007;51:714-25.
29. Kay CD. Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans. Nutr Res Rev 2006;19:137-46.
30. Talavera S, Felgines C, Texier O, et al. Anthocyanins are efficiently absorbed from the small intestine in rats. J Nutr 2004;134:2275-9.
31. Ravoori S, Vadhanam MV, Sahoo S, Srinivasan C, Gupta RC. Mammary tumor induction in ACI rats exposed to low levels of 17β-estradiol. Int J Oncol 2007;31:113-20.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 2001;25:402-8.
33. Shull JD, Spady TJ, Snyder MC, Johansson SL, Pennington KL. Ovary-intact, but not ovariectomized female ACI rats treated with 17β-estradiol rapidly develop mammary carcinoma. Carcinogenesis 1997;18:1595-601.
34. Kurz SG, Hansen KK, McLaughlin MT, et al. Tissue-specific actions of the Ept1, Ept2, Ept6, and Ept9 genetic determinants of responsiveness to estrogens in the female rat. Endocrinology 2008;149: 3850-9.
35. Ruhlen RL, Willbrand DM, Besch-Williford CL, Ma L, Shull JD, Sauter ER. Tamoxifen induces regression of estradiol-induced mammary cancer in the ACICOP-Ept2 rat model. Breast Cancer Res Treat 2009;117:517-24.
36. Shull JD, Lachel CM, Murrin CR, et al. Genetic control of estrogen action in the rat: mapping of QTLs that impact pituitary lactotroph hyperplasia in a BNXACI intercross. Mamm Genome 2007;18:657-69.
37. Mense SM, Singh B, Remotti F, Liu X, Bhat HK. Vitamin C and α-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats. Carcinogenesis 2009;30: 1202-8.
38. Singh B, Mense SM, Remotti F, Liu X, Bhat HK. Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats. J Biochem Mol Toxicol 2009;23: 202-11.
39. Cribb AE, Knight MJ, Dryer D, et al. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cancer Epidemiol Biomarkers Prev 2006;15:551-8.
40. Liehr JG. Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update 2001;7:273-81.
41. Christou M, Savas U, Schroeder S, et al. Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones. Mol Cell Endocr 1995;115:41-50.
42. Barch DH, Rundhaugen LM, Thomas PE, Kardos P, Pillay NS. Dietary ellagic acid inhibits the enzymatic activity of CYP1A1 without altering hepatic concentrations of CYP1A1 or CYP1A1 mRNA. Biochem Biophys Res Commun 1994;201:1477-82.
43. Risk M, Shehu A, Mao J, et al. Cloning and characterization of a 5′ regulatory region of the prolactin receptor-associated protein/17β hydroxysteroid dehydrogenase 7 gene. Endocrinology 2005;146: 2807-16.
44. Li KM, Todorovic R, Devanesan P, et al. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 2004;25:289-97.
45. Mesia-Vela S, Sanchez RI, Roberts KG, Reuhl KR, Conney AH, Kauffman FC. Dietary clofibrate stimulates the formation and size of estradiol-induced breast tumors in female August-Copenhagen Irish (ACI) rats. Toxicology 2008;246:63-72.
46. Moyer RA, Hummer KE, Finn CE, Frei B, Wrolstad RE. Anthocyanins, phenolics, and antioxidant capacity in diverse small fruits: vaccinium, rubus, and ribes. J Agric Food Chem 2002;50:519-25.
47. Wang LS, Hecht SS, Carmella SG, et al. Anthocyanins in black raspberries prevent esophageal tumors in rats. Cancer Prev Res 2009;2: 84-93.